Hot Investor Mandate 7: VC Firm with Capital from Family Offices Invests in Biotech Companies in North America and Europe

23 Nov

A venture capital firm allocates capital sourced from family offices based in Europe and is also raising a seed fund focusing on investments in the biopharma space. The firm’s principals generally participate in seed to Series A financing rounds, making equity investments in the range of € 0.1-2 M. The firm invests globally with a focus on North America and Europe.

The firm seeks early stage biotech companies in Europe and North America that develop first or best in class therapeutic agents, currently in pre-clinical and phase I, across all indications. The firm is also considering select later-stage opportunities in medical devices, diagnostics, or healthcare IT as requested by family offices for direct investments.

The firm looks for startups that will be highly attractive for large companies after proof of concept in man. The firm is open to working as early as the time of technology transfer, with academic founding teams that demonstrate strong technical expertise in their field and the willingness to embark complementary management, including a proven CEO.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: